{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:58:18Z","timestamp":1787662698855,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["21Y11900300"],"award-info":[{"award-number":["21Y11900300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFE0205500"],"award-info":[{"award-number":["2020YFE0205500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.radonc.2024.110578","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:11:42Z","timestamp":1728605502000},"page":"110578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["p16 status or response to induction chemotherapy, which predicts survival outcomes in Chinese oropharyngeal cancer treated with definitive radiotherapy?"],"prefix":"10.1016","volume":"201","author":[{"given":"Ruichen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110578_b0005","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.annonc.2020.07.011","article-title":"Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Machiels","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2024.110578_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8101497","article-title":"Pathological and Virological Studies of p16-Positive Oropharyngeal Carcinoma with a Good Response to Neoadjuvant Chemotherapy","volume":"8","author":"Inukai","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.radonc.2024.110578_b0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40463-018-0302-y","article-title":"The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): an extensive review","volume":"47","author":"Liu","year":"2018","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2024.110578_b0020","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3322\/caac.21758","article-title":"Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancer","volume":"73","author":"Kang","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2024.110578_b0025","doi-asserted-by":"crossref","unstructured":"Lydiatt WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):122-37.","DOI":"10.3322\/caac.21389"},{"key":"10.1016\/j.radonc.2024.110578_b0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2024.110578_b0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2024.110578_b0040","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110578_b0045","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2217\/fon-2016-0502","article-title":"Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part I: carcinoma of non-nasopharyngeal sites","volume":"13","author":"Chapman","year":"2017","journal-title":"Future Oncol"},{"key":"10.1016\/j.radonc.2024.110578_b0050","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/hed.27119","article-title":"Induction chemotherapy of modified docetaxel, cisplatin, 5-fluorouracil for laryngeal preservation in locally advanced hypopharyngeal squamous cell carcinoma","volume":"44","author":"Li","year":"2022","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2024.110578_b0055","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00405-023-08223-2","article-title":"Neoadjuvant chemotherapy for organ preservation in sinonasal squamous cell carcinoma","volume":"281","author":"Wang","year":"2024","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.radonc.2024.110578_b0060","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.oraloncology.2019.06.015","article-title":"Induction chemotherapy in head and neck cancers: Results and controversies","volume":"95","author":"Gau","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2024.110578_b0065","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1470-2045(21)00076-0","article-title":"Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis","volume":"22","author":"Petit","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110578_b0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2023.07.037","volume":"118","author":"Xu","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110578_b0075","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.oraloncology.2008.11.015","article-title":"Analysis of 724 cases of primary head and neck squamous cell carcinoma (HNSCC) with a focus on young patients and p53 immunolocalization","volume":"45","author":"De Paula","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2024.110578_b0080","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1200\/JCO.22.02625","article-title":"Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States","volume":"41","author":"Chaturvedi","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110578_b0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jamaoto.2021.3567","article-title":"Oropharyngeal Cancer Incidence and Mortality Trends in All 50 States in the US, 2001\u20132017","volume":"148","author":"Damgacioglu","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2024.110578_b0090","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1600-0463.2010.02624.x","article-title":"The role of human papillomavirus in head and neck cancer","volume":"118","author":"Lajer","year":"2010","journal-title":"APMIS"},{"key":"10.1016\/j.radonc.2024.110578_b0095","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","article-title":"HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management","volume":"19","author":"Lechner","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110578_b0100","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.3390\/v7072802","article-title":"Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia","volume":"7","author":"Egawa","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.radonc.2024.110578_b0105","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1200\/JCO.19.00370","article-title":"Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals","volume":"37","author":"Tota","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110578_b0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.oraloncology.2016.12.001","article-title":"Truth or myth: Definitive chemoradiotherapy doesn't work for HPV\/p16 negative oropharyngeal squamous cell carcinoma?","volume":"65","author":"Chera","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2024.110578_b0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2024.110578_b0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0360-3016(02)03792-6","article-title":"Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy\u2013a multicenter randomized trial","volume":"55","author":"Olmi","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110578_b0125","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1002\/cncr.27609","article-title":"Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN)","volume":"118","author":"Ang","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2024.110578_b0130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(13)70011-1","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial","volume":"14","author":"Haddad","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110578_b0135","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv368","article-title":"Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, \u00b1 Docetaxel for Larynx Preservation","volume":"108","author":"Janoray","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2024.110578_b0140","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/annonc\/mdn752","article-title":"Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation","volume":"20","author":"Posner","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2024.110578_b0145","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/annonc\/mdr006","article-title":"Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial","volume":"22","author":"Posner","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2024.110578_b0150","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11864-022-00941-9","article-title":"Induction Chemotherapy in Low-Risk HPV+ Oropharyngeal Cancer","volume":"23","author":"Dolezal","year":"2022","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.radonc.2024.110578_b0155","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1200\/JCO.2016.68.3300","article-title":"E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group","volume":"35","author":"Marur","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110578_b0160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/annonc\/mdy522","article-title":"OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer","volume":"30","author":"Seiwert","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2024.110578_b0165","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2016.05.026","article-title":"Prognostic Value of p16 Status on the Development of a Complete Response in Involved Oropharynx Cancer Neck Nodes After Cisplatin-Based Chemoradiation: A Secondary Analysis of NRG Oncology RTOG 0129","volume":"96","author":"Galloway","year":"2016","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2024.110578_b0170","doi-asserted-by":"crossref","first-page":"9175","DOI":"10.1002\/cam4.5656","article-title":"Response to induction chemotherapy predicts survival outcomes in oropharyngeal cancer","volume":"12","author":"Zhang","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.radonc.2024.110578_b0175","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nrc1506","article-title":"Gefitinib\u2013a novel targeted approach to treating cancer","volume":"4","author":"Herbst","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2024.110578_b0180","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.2165\/10489100-000000000-00000","article-title":"Gefitinib: a review of its use in the treatment of locally advanced\/metastatic non-small cell lung cancer","volume":"69","author":"Sanford","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.radonc.2024.110578_b0185","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.radonc.2024.110578_b0190","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1158\/1078-0432.CCR-04-1245","article-title":"High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan","volume":"10","author":"Huang","year":"2004","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.radonc.2024.110578_b0195","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma","volume":"33","author":"Gillison","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110578_b0200","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.surge.2018.04.009","article-title":"Survival outcome of tonsillar squamous cell carcinoma (TSCC) in the context of human papillomavirus (HPV): A systematic review and meta-analysis","volume":"17","author":"Ahmadi","year":"2019","journal-title":"Surgeon"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024035564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024035564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T19:19:42Z","timestamp":1732303182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024035564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":40,"alternative-id":["S0167814024035564"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110578","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"p16 status or response to induction chemotherapy, which predicts survival outcomes in Chinese oropharyngeal cancer treated with definitive radiotherapy?","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110578"}}